Trial intelligence / Profile preview

Alendronate for Bone Microarchitecture in Early Postmenopausal Women

NCT00504166Phase 4Completed

Sponsor
University of California, San Francisco
Start
Feb 2006
Primary completion
Mar 2009
Countries
1
01

Overview

A Phase 4 trial of alendronate in osteopenia, osteoporosis, sponsored by University of California, San Francisco. Started Feb 2006; status: completed.

02

Drugs

alendronate
03

Conditions

osteopeniaosteoporosis

Beyond the preview

Go deeper on NCT00504166.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00504166.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call